Tag: <span>Parkinson’s disease</span>

Home / Parkinson’s disease
Post

Why a diabetes drug could help in Parkinson’s disease

A diabetes drug might help in certain types of Parkinson’s disease, reports a team of German brain researchers headed by Dr. Julia Fitzgerald at the Hertie Institute for Clinical Brain Research, the University of Tübingen and the German Center for Neurodegenerative Diseases in Tübingen. The neuroscientists identified a protein that plays an important role in...

Post

Using asthma inhalers HALVES the risk of developing Parkinson’s disease in old age, ‘landmark’ study finds

It is believed the drug stops abnormal protein clumps accumulating in the brain The findings were made by a team of Norwegian and Harvard University experts They hope it could lead to potential new treatments for the incurable disease Asthma inhalers may protect patients from Parkinson’s disease, a major new study suggests. Full of salbutamol,...

Post

Scientists devise ‘promising’ new stem cell treatment that has the ‘potential to cure Parkinson’s disease’ and stop tremors

In trials on laboratory monkeys, researchers were able to restore nerve cells In humans, the disease causes a loss of neurons, which affects movement Experts hailed the findings of the Japanese study to be ‘extremely promising’ A pioneering new stem cell treatment with the ‘potential to cure Parkinson’s disease’ has been crafted by researchers. In...

Post

Parkinson’s sufferers who SING could delay the onset of crippling symptoms such as losing their ability to swallow

Muscles worked in singing also are used during swallowing and respiratory functions  Experts from Iowa State University created musical therapy classes   Participants who attended the classes reported it significantly helped their throat muscles that had declined due to Parkinson’s  Four cities in Iowa now offer these classes for those with the disease Singing could...

Post

Telemedicine as effective as in-person care for Parkinson’s disease

New findings from a nationwide program that links neurologists with patients with Parkinson’s disease in their homes via video conferencing shows that telemedicine can successfully deliver quality care. The study, which appears today in the journal Neurology, points to a new way to improve care for people who suffer from the disease, but may have not...

Post

Diabetes drug shows potential as disease-modifying therapy for Parkinson’s disease

A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson’s disease, a new UCL-led study suggests, paving the way for further research to define its efficacy and safety. The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), found that people with Parkinson’s who injected...

Post

New drug may treat and limit progression of Parkinson’s disease

BINGHAMTON, NY – Researchers at Binghamton University have developed a new drug that may limit the progression of Parkinson’s disease while providing better symptom relief to potentially hundreds of thousands of people with the disease. Symptoms of Parkinson’s disease are commonly managed using a selective dopamine receptor agonists. While these drugs are useful in early-stage...

Post

Immune system may mount an attack in Parkinson’s disease

A new study suggests that T cells, which help the body’s immune system recognize friend from foe, may play an important role in Parkinson’s disease (PD). The study, published in the journal Nature, was supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. “This collaboration between...

Post

Transcranial stimulation and/or physical therapy improves walking speed in Parkinson’s disease

Noninvasive brain stimulation and physical therapy — alone or in combination — improve some measures of walking ability in patients with Parkinson’s disease (PD), concludes a clinical trial in the American Journal of Physical Medicine & Rehabilitation, the official journal of the Association of Academic Physiatrists. The journal is published by Wolters Kluwer. Transcranial direct current...